Thuja Capital Healthcare Fund III invests in Pan Cancer T
Pan Cancer T, a biotechnology spin-out from Erasmus MC, announced the closing of an extended seed investment round. All of their current shareholders participated, with Thuja Capital joining as a new investor. Pan Cancer